Mabit H, Vons C, Dubanchet S, Capel F, Franco D, Petit M A
Institut National de la Santé de la Recherche Médicale Unité, Unité, Clamart, France.
J Hepatol. 1996 Apr;24(4):403-12. doi: 10.1016/s0168-8278(96)80160-7.
BACKGROUND/AIMS: We analyzed the hepatitis B virus envelope specificities (HBs, preS2 and preS1) involved in virus attachment to normal human hepatocytes, and we performed in vitro hepatitis B virus infection experiments without addition of dimethyl sulfoxide and polyethylene glycol, which may affect cell membrane integrity, in order to study further the early steps of the life cycle of the hepatitis B virus.
Primary normal human hepatocytes were prepared from surgical biopsies by the two-step collagenase perfusion technique, and cultured in a fetal calf serum-free medium supplemented with 10(-6) M dexamethasone. Cell-binding assays, ligand blotting and immunohistochemistry experiments were carried out using our anti-idiotypic (Ab2) antibodies (Ab2s/preS1, Ab2s/preS2 and Ab2s/HBs).
Probing primary normal human hepatocytes, the 35-kDa major preS1-binding protein (preS1-BP35) we have previously identified in human hepatoma HepG2 cells was recognized in blotting, whereas both HBs- and preS1-specificities of the hepatitis B virus envelope interacted strongly with normal human hepatocyte cell membrane in cell-binding assays and immunohistochemistry experiments. Hepatitis B virus infectivity studies confirmed a great inter-experimental variability depending on donors and liver perfusion, and demonstrated a great intra-experimental variability depending on the serum-derived hepatitis B virus isolate used for the inoculation. In our culture conditions, only increased detection of the RC and CCC DNA forms of hepatitis B virus in cells and of hepatitis B virus surface antigens in medium was observed 4 to 8 days after exposure of cells to hepatitis B virus.
These findings support a potential role for preS1-BP35 as a receptor protein for hepatitis B virus. In our hands, limitation(s) in the hepatitis B virus life cycle may occur at some step after virion binding, and likely result from complex regulation of reverse transcription of the RNA and translation of core protein by extrahepatic host factors or/and by the virus itself. However, the normal human hepatocyte model developed here is available for studying the initial steps in hepatitis B virus entry into cells.
背景/目的:我们分析了乙肝病毒包膜特异性(HBs、preS2和preS1)在病毒附着于正常人肝细胞过程中的作用,并进行了体外乙肝病毒感染实验,实验中未添加可能影响细胞膜完整性的二甲基亚砜和聚乙二醇,以便进一步研究乙肝病毒生命周期的早期步骤。
采用两步胶原酶灌注技术从手术活检组织中制备原代正常人肝细胞,并在添加10(-6)M地塞米松的无胎牛血清培养基中培养。使用我们的抗独特型(Ab2)抗体(Ab2s/preS1、Ab2s/preS2和Ab2s/HBs)进行细胞结合试验、配体印迹和免疫组织化学实验。
在用印迹法检测原代正常人肝细胞时,我们之前在人肝癌HepG2细胞中鉴定出的35 kDa主要preS1结合蛋白(preS1-BP35)被识别,而在细胞结合试验和免疫组织化学实验中,乙肝病毒包膜的HBs和preS1特异性均与正常人肝细胞细胞膜强烈相互作用。乙肝病毒感染性研究证实,实验间存在很大差异,这取决于供体和肝脏灌注情况,并且实验内也存在很大差异,这取决于用于接种的血清来源乙肝病毒分离株。在我们的培养条件下,细胞暴露于乙肝病毒后4至8天,仅观察到细胞中乙肝病毒RC和CCC DNA形式以及培养基中乙肝病毒表面抗原的检测增加。
这些发现支持preS1-BP35作为乙肝病毒受体蛋白的潜在作用。在我们的研究中,乙肝病毒生命周期的限制可能发生在病毒粒子结合后的某个步骤,可能是由于肝外宿主因素或/和病毒本身对RNA逆转录和核心蛋白翻译的复杂调节所致。然而,这里建立的正常人肝细胞模型可用于研究乙肝病毒进入细胞的初始步骤。